Felis ISSN 2398-2950

Scintigraphy: hepatic for PSS

Contributor(s): Fraser J McConnell

Introduction

  • Use of radionucleotide allows some assessment of function and structure of organ.
  • Technetium (99MTc) is rapidly absorbed through the colonic mucosa   →   portal blood stream (<15% of original dose is absorbed).
  • Absorbed Tc is unaffected in liver or heart and, in normal animal radioactivity, appears in liver within 8-10 sec after administration of radionucleotide.
  • A 6-12 sec delay should occur before radioactivity is seen in the heart depending on the circulation time, ie patient size.
  • Used commonly in human medicine.

Uses

Advantages

  • Non-invasive.
  • Quantifies magnitude of shunt flow.

Disadvantages

  • Cost.
  • Limited availability.
  • Radiation hazard (minimal).
  • May not identify location of shunt.
  • Requires patient to be isolated for a period after injection of radionucleotide.

Requirements

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Preparation

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Procedure

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Aftercare

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Outcomes

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Meyer H P, Rothuizen J, van den Brom W E et al (1994) Quantitation of portosystemic shunting in dogs by ultrasound-guided injection of 99MTc-macroaggregates into a splenic vein. Res Vet Sci 57 (1), 58-62 PubMed.
  • Van Vechten B J, Komtebedde J & Koblik P D (1994) Use of transcolonic portal scintigraphy to monitor blood flow and progressive post-operative attenuation of partially ligated single extrahepatic portosystemic shunts in dogs. JAVMA 204 (11), 1770-1774 PubMed.


ADDED